Among the many applications for carbon nanotubes (CNTs), their use in medicine has drawn special attention due to their potential for a variety of therapeutic and diagnostic applications. As progress toward clinical applications continues, monitoring CNTs in vivo will be essential to evaluate their biodistribution, potential toxicity, therapeutic activity, and any physiological modifications that the material may induce in specific tissues. There are many different imaging modalities to visualize and track CNTs in vivo, yet only a few are full-body penetrating, a central characteristic that widens their clinical utility. In order to visualize CNTs, chemical modification is often required for the material to be used as a platform to carry imaging agents compatible with one or more of the clinical imaging techniques. Here, we focus on the most recent work involving the use of CNTs as imaging agents for the non-invasive, full-body penetrating clinical modalities of MRI, PET, SPECT, and X-ray CT. The synthesis and modification of the CNT materials are discussed, as well as relevant preclinical studies.
Introduction
Among the many nanoparticles currently under investigation, carbon nanotubes have been and continue to be a key material for their unique properties, cost effectiveness, and extreme diversity of applications. Carbon nanotubes (CNTs) can be described as graphene sheets that are rolled in a cylindrical shape and have different electrical and optical properties depending on the axis about which they are rolled, which is called chirality or the "twist" of the nanotube. The different CNT chiralities include the armchair structure, in which the C-C bonds are perpendicular to the tube axis; the zig-zag structure, in which the C-C bonds are parallel to the tube axis; and the chiral structure, in which the C-C bonds lie at an angle with respect to the tube axis [1, 2] . CNTs are either single-walled (SWCNTs) with a diameter around 1-2 nm, or multiwalled (MWCNTs), which are composed of 2-30 concentric SWCNTs with an outer diameter ranging from 10 to100 nm. Some of the methods that are generally used to produce CNTs are arcdischarge, laser-ablation, and chemical vapor deposition, including the high-pressure carbon monoxide (HiPCO) synthesis. These processes usually occur in the presence of transition metal (Co, Fe, Ni) or rare earth (Gd, Y) catalysts, which remain in the pristine CNT product [3] [4] [5] [6] [7] [8] [9] ; significant progress has been accomplished in the removal of trace amounts of these catalysts [9] [10] [11] [12] [13] , although more work is currently underway. Since their discovery [14] , CNTs have been of great interest because of their unique structural and chemical properties, such as their high tensile strength, high aspect ratio, and the capability to be chemically functionalized, while remaining relatively inert [15] [16] [17] [18] . This interest has led to CNTs being used in a variety of applications in electronics [19, 20] , material composites [21] , energy [22] , catalyst supports [23, 24] , and particularly those in the medical field [25] [26] [27] . Within the emerging field of nanomedicine, CNTs have been investigated as drug delivery vectors [28, 29] , therapeutic agents exploiting microwave-, photo-, or radiofrequency-induced thermal effects [30] [31] [32] [33] , scaffolds for tissue engineering [34] , and diagnostic imaging agents [35, 36] .
For diagnostic and therapeutic applications, it is essential to determine the CNT biodistribution and pharmacokinetic profile to study the biological effects of the material on specific tissues. To this end, researchers have used a wide range of imaging modalities that rely on the intrinsic properties of CNTs. These techniques include Raman scattering [37] , high optical and near infrared (NIR) absorbance, and photoluminescence [38] [39] [40] , photoacoustic [41] [42] [43] [44] , thermoacoustic [45] , and echogenic properties [46] . However, some of these imaging techniques suffer from penetration depth limitations, poor spatial resolution, or poor soft-tissue contrast [47, 48] . To combat these limitations, CNTs may be employed as a scaffold or capsule for radionuclides or ions that are used for the noninvasive, full-body penetrating clinical modalities, such as magnetic resonance imaging (MRI), single-photon emission computed tomography (SPECT), positron emission tomography (PET), and X-ray computed tomography (X-ray CT) (see Figure 1 ). While common imaging contrast agents (CAs) generally are not able to cross the cell membrane, the use of CNTs allows for these agents to be delivered intracellularly for cell tracking and sometimes selectively with the use of biological targeting moieties. Packaging the imaging agents onto or inside the CNTs enables them to be internalized by cells [49] without the need of cytotoxic transfection agents [50, 51] . However, the highly hydrophobic nature of CNTs also prohibits their suspension in aqueous media, requiring covalent or non-covalent functionalization techniques to produce biocompatibility and high aqueous suspendability (see Figure 2 ). Several reviews discussing extensively the different methods for CNT functionalization have been previously published [52] [53] [54] , as well as reviews on the use of CNTs for imaging [35, 36, [55] [56] [57] ; however, the rapid growth in the field constantly prompts an updated discussion of current findings. For this reason, this review focuses primarily on recent clinically relevant work involving exclusively non-invasive full-body penetrating techniques reported within the past five years. 
CNT-based Agents for MRI
Among the imaging techniques used in the clinic, MRI offers the advantage of highquality anatomical images with high spatial resolution without the use of ionizing radiation.
Instead, MRI utilizes a high-intensity magnetic field that aligns the nuclear magnetization of hydrogen atoms in water molecules within the body, taking advantage of the difference in water concentration among tissues to produce images. are the proton relaxation times. The theoretical basis for the relaxivity of paramagnetic and superparamagnetic agents has been extensively described in the literature [58] [59] [60] [61] [62] . In order to produce an MRI-active CNT CA, a paramagnetic or superparamagnetic agent must be conjugated to or encapsulated within the CNT platform.
Gadolinium-based Contrast Agents
The first CNT-based MRI CA containing Gd 3+ was reported in 2005 by Sitharaman et al.,
and was termed the "Gadonanotube" or GNT [63, 64] . The CA consisted of ultra-short nm) single-walled carbon nanotubes (US-SWCNTs) loaded with Gd 3+ ion clusters (3-4% Gd by weight, see Figure 3A and 3B [65] , which is critical for clinical applications given the high toxicity of free Gd 3+ [66] . Usually, a 0.17% Pluronic ® F-108 solution is used to suspend the GNTs in an aqueous medium for in vitro studies. In subsequent reports, GNTs were used to label macrophage cells [67] , mesenchymal stem cells (see Figure 3C and 3D) [68, 69] , and HeLa cells [70] . In all cases, GNTs localized in the cytoplasm of the cell, delivering about 10 9 Gd 3+ ions per cell. In another study, GNTs were covalently derivatized with D,L -serine amino acid substituents to produce water-suspendable (2 mg/mL) "ser-GNTs," which were then used to label MCF-7 human breast cancer cells with no observable cytotoxic effects or morphologic changes [71] . wt. % for the acac, hfac, and thd chelates, respectively. To further decipher the structural origin of the exceedingly high-performance MRI contrast of the GNTs, a more detailed extended X-ray absorption fine structure (EXAFS) study was performed [73] , revealing essential information about the dynamic system around the clustered Gd 3+ ions within the US-SWCNTs.
In another attempt to produce highly water-suspendable GNTs, following the encapsulation of the Gd 3+ ions, the surface of the US-SWCNTs was functionalized with pcarboxyphenyldiazon ium (PCP) tetrafluoroborate salt, which covalently attached benzoic acid moieties, making the material highly water-suspendable (35 mg/mL) [74] . However, 90% of the Gd 3+ ions leaked from the SWCNTs due to the acidic conditions of the functionalization process.
To address this issue, US-SWCNTs, encapsulating the Gd(acac) 3 ·2H 2 O and Gd(hfac) 3 ·2H 2 O chelates were synthetized and the surface of the resulting material was functionalized with PCP, producing stable, highly water-suspendable US-SWCNTs containing 2.5 -3.8% Gd by weight.
These water-suspendable US-SWCNTs, encapsulating Gd(acac) 3 ·2H 2 O, were then used to label porcine mesenchymal stem cells, making the cells MRI active without affecting cell viability [74] .
Recently, the magnetic properties of metal impurities present in raw, commercially available CNTs (mainly from iron and nickel catalysts) have been studied for T 2 -based contrast signal enhancement. A similar approach was employed to synthetize a Gd-based CA using Gd 2 O 3 nanoparticles as catalysts to synthesize SWCNTs (Gd-SWCNTs) via chemical vapor deposition
for T 1 -weighted MRI [75] [76] [77] . The Gd 3+ content of the final product was reported to be 6.2% and aqueous suspendability was achieved by non-covalent functionalization with a phospholipid polymer, PEG 5400 -DSPE (PEG = polyethylene glycol, DSPE = 1,2-distearoyl-sn-glycero-3-phosphoethanolamine) [77] . The cell-labeling efficacy was tested for NIH/3T3 fibroblast cells, which showed no change in viability, proliferation, or changes in their division cycle compared to untreated controls. Gd-SWCNTs localized to the cytoplasm and delivered 10 8 -10 9 Gd 3+ ions per cell. Phantom studies of the labeled cells using a T 1 -weighted MRI at 3 T showed a four-fold increase in MR signal intensities compared to unlabeled cells. A continuation study [78] by the same group evaluated the in vivo pharmacodynamics of Gd-SWCNTs after intravenous (i.v.) injection (0.5 mg/kg) in male Wistar rats, which was assessed by bright-field optical microscopy.
The macroscale distribution of the material showed uptake in the lungs, liver, kidneys, brain, and spleen. The histological distribution was also assessed and the molecular and genetic responses were evaluated for up to 30 days. After 24 h, the Gd-SWCNT material accumulated in different organs leaving the circulatory system, with total elimination occurring in 10 days. However, in vivo MRI data for the Gd-SWCNTs were not obtained in any of the studies discussed above. 
An alternative approach to synthetize CNT-based CAs containing Gd

Iron-based Contrast Agents
As mentioned above, superparamagnetic iron oxide nanoparticles (SPIONs) have also µg/mL, and T 2 -weighted MR images of a cancerous mouse liver showed an increased tumor/liver contrast ratio after administration of the material ( Figure 6 ). Another theranostic agent consisting of a ferromagnetic material encapsulated inside MWCNTs has been reported by Peci et al., however in this case, the magnetic material was in the form of a wire [86] . The iron nanowire, termed iron-filled MWCNTs (Fe-MWCNTs), displayed high coercivity due to shape anisotropy, promoting its use in cancer therapy as a magnetic hyperthermia agent. In this case, the authors added Gd 3+ ions to the surface of the Fe-MWCNTs by sonication with GdCl 3 , which resulted in attachment of Gd 3+ ions on the MWCNT sidewalls.
This resulted in a dual-function agent owing to the integration of both the heating element (the Fe nanowire) and the paramagnetic Gd 3+ ions that generated MRI contrast. Although the structures were well characterized, no MR images were reported and the biological stability of the Gd 3+ ions
was not evaluated.
A T 2 -weighted MRI signal is also observed from CNTs containing metal impurities such as iron and nickel. Such a phenomenon was exploited to study the chronic toxic effect of raw SWCNTs to the lungs through a long-term (3 months) follow-up study that was achieved by hyperpolarized helium-3 (HP- 3 He) MRI [87] , a technique that is used for clinical pulmonary research and has been described previously [88] . Intratracheal instillation of SWCNTs was performed in rats and the amount of metal impurities in the CNTs were large enough to produce a significant drop in magnetic field homogeneity as detected in the 3 He MR images. In another study, MRI in conjunction with Raman spectroscopy and iron bio-assays, was used to assess the biodistribution of intravenously injected pristine (raw and purified) and functionalized SWCNTs in a two-week study [89] . The intrinsic iron impurities (11% by weight) in the raw sample allowed the in vivo detection of SWCNTs by MRI. In a similar report, commercial HiPCO SWCNTs were non-covalently coated with amine-terminated PEG and relaxivity values, as well as two-dimensional images of solid phantoms were acquired [90] . The trace amount of iron in the sample was sufficient to distinguish a difference from the background in the MRI scan at nanomolar concentrations.
The potential of MWCNTs with low metal impurities (2.57% Fe by weight) as intracellular MRI CAs was exploited by Vittorio and coworkers [91] . A solution of 0.1% Pluronic ® F127 in phosphate-buffered saline (PBS) was used to make an aqueous suspension of the MWCNTs and mesenchymal stem cells from the bone marrow of rats were used for in vitro studies. MR images of the CNT suspension and of labeled cells at different CNT concentrations showed that the low Fe content in the CNTs was sufficient to visualize the cells by T 2 -weighted MRI. As shown above, MRI provides a very efficient method for tracking CNTs as well as tracking cells using CNT-based intracellular probes since MR images elucidate anatomical structures with very high resolution. However, MRI is limited by its low sensitivity, which requires large concentrations (e.g. 1 mM) in order to produce high quality images when using a CA.
CNT-based Agents for Nuclear Imaging
Among the nuclear imaging techniques, SPECT and PET have become important tools in both clinical and research settings. The way a SPECT image is generated is by having one or two detectors rotate to identify gamma (γ) rays emitted from a decaying radionuclide inside the patient and convert the detected energy into an electrical signal, which is then processed into an image. In PET imaging, radionuclei release positrons (β + ), which interact with electrons in their vicinity and annihilate one another, emitting two γ rays 180° with respect to each other with identical energies of 511 keV. The γ rays are detected by a ring of detectors that register coincident rays coming from a single event along a given line of response. In both types of imaging, two-dimensional cross-sections of the subject from multiple angles can be reconstructed and stacked to create a three-dimensional image [92] . When compared to MR and X-ray imaging techniques, which offer structural information with very high resolution, nuclear imaging techniques offer functional information and the ability to quantitatively track material in vivo with very high sensitivity. PET is a far more sensitive technique than SPECT, requiring material concentrations of only 10 -10 to 10 -12 M, whereas SPECT requires concentrations of about 10 -6 M.
Furthermore, PET often has higher resolution (2-3 mm) than SPECT (6-8 mm) [93, 94] .
CNT-based Agents for SPECT
Hong et al. filled short SWCNTs (approximately 300 nm in length) with Na 125 I (t 1/2 = 59 d) and determined tissue localization using SPECT [95] . In this report, the authors first Meanwhile, MWCNT 8 showed reduced liver accumulation and greater renal excretion in contrast with the other samples, which aggregated and remained in the liver, spleen, and lungs (see Figure 7) . The authors of this study and others have also previously reported [98, 99] 
CNT-based Agents for PET
McDevitt and coworkers developed an amine-functionalized SWCNT material that was conjugated to both the tumor neovascular-targeting antibody E4G10 and to one of two different metal chelates that contained either 225 Ac 3+ , an alpha emitter for radiotherapy (t 1/2 = 10 d) chelated by 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), or 89 Zr 4+ , a β + emitter for PET imaging (t 1/2 = 78 h) chelated by desferrioxamine B [100] . Using the targeted, radiolabeled SWCNT material resulted in an approximately five-fold increase in specific activity, which improved the signal-to-noise ratio of the image. Another study by Huang et al. examined the effects on fetotoxicity of water-suspendable SWCNTs and MWCNTs and used PET to study material localization in pregnant mice and their fetuses [101] . The CNTs were non-covalently functionalized using an amino-phospholipid-poly(ethylene glycol) (PL-PEG-NH 2 ) derivative as previously reported [102] with DOTA then conjugated to the CNTs in order to radiolabel the material with 64 The fetuses were then harvested and imaged at 48 h post-injection and showed CNT uptake in the fetal liver and placenta. The authors concluded that functionalized MWCNTs (particularly MWCNT-50) more readily induced toxicity in mouse fetuses than other derivatives at similar doses. Since the biodistribution and the uptake values of the CNTs were similar, the study concluded that any toxicity that was observed must not be from the amount of uptake, but from other properties of the CNTs, such as the diameter, agglomeration state, etc. These and other studies have concluded that among all the nuclear medicine techniques, SPECT and PET can be used to effectively track minute amounts of material in vivo due to their high sensitivity.
CNT-based Agents for X-ray CT
Despite the introduction and growth of MR, ultrasound, and nuclear imaging systems, Xray remains one of the main imaging modalities today due to its cost-effectiveness and diverse applicability. X-ray CT combines multiple X-ray projections taken from different angles to produce detailed cross-sectional images of the body. Contrast enhancement comes largely from the photoelectron effect due to high atomic numbers, thus hard tissue such as bone and cartilage have high attenuation compared to soft tissues due to the high concentration of calcium.
Currently, there are two types of approved X-ray CAs for human use: barium sulfate suspensions (strictly used for imaging the gastrointestinal tract) and iodinated molecules. There are many elements with larger atomic numbers than iodine, thus the current use of iodinated CAs is mostly based on their superior safety and cost rather than their optimal efficacy as X-ray attenuators [103] . Some metals, metal salts, and metal particulates have been shown to be excellent X-ray CAs, such as bismuth sulfide [104, 105] and gold nanoparticles [106, 107] .
Little research involving CNT-based CAs for X-ray has been developed, mostly due to the high CA concentration needed to produce good contrast and the poor water solubility and dispersion achieved with CNTs in aqueous media. Previously, functionalized US-SWCNTs (20-80 nm) filled with I 2 were synthetized and the X-ray attenuation was tested, although no in vitro or in vivo studies were performed [108] . More recently, Bi 3+ ions and Bi 2 O 3 were encapsulated in US-SWCNTs using BiCl 3 as the bismuth source, followed by suspension of the material in a 0.17% Pluronic ® solution. Bismuth was chosen as a substitute for iodide due to its higher atomic number and lower toxicity [109, 110] . In vitro studies were performed in porcine mesenchymal stem cells, causing no observed cytotoxicity to the cells while increasing the X-ray attenuation when compared with control cells [111] . With today's technology, single-cell tracking using CT is not promising [112] , however, 3D structures of cells such as stem cell-engineered cell sheets, cells encapsulated in hydrogels or capsules, among others, can be monitored with CT [113] [114] [115] .
In general, CT still is one of the most used clinical modalities and more efforts regarding the development of new CAs should be considered in order to limit the radiation dose to the patient.
CNT-based Agents for Multimodal Imaging
Currently, nuclear images are often overlaid with a CT image to generate a composite image, which provides anatomical information for image analysis. However, due to the much [118] . PET The arrows highlight the presence of 64 Cu 2+ in the liver (white arrow) and gastrointestinal tract (yellow arrow) for free 64 In vivo MR images were also obtained of the liver using S-MWCNT-3, which showed good relaxation rates that increased linearly with increasing dose of material. In vitro studies of S-MWCNT-3 using a mouse macrophage cell line with concentrations up to 100 µg/mL after 24 h incubation found no significant cytotoxicity in addition to any histological abnormalities in mouse tissues up to 30 days.
Similarly, Al Faraj and coworkers recently developed a multifunctional SWCNT agent conjugating SPIONs and gallium-67 (t 1/2 = 3.26 days) for MRI and SPECT, respectively, in order to target and image breast cancer stem cells [120] . SWCNTs were oxidized and shortened to about 200 nm in length. The oxidized CNTs were then PEGylated and conjugated to SPIONs and DOTA to chelate gallium-67 for imaging, in addition to CD44 monoclonal antibodies for cancer stem cell targeting. SPECT imaging studies in mice showed significant material accumulation in reticuloendothelial organs (liver and spleen) as well as the kidneys and heart, but to a lesser extent. Tumor homing was enhanced after injection of the antibody-conjugated samples compared to untargeted controls. SPECT data were confirmed using MRI and post-mortem gallium-67 quantification using a gamma counter. Since the amount of material accumulation at 2, 24, and 48 h time points was statistically similar, the authors suggested that the material was cleared slowly from the mouse. The authors also substituted the gallium-67 for a near-infrared fluorescence probe and conducted imaging studies, which yielded very similar results as the SPECT and MRI studies. With the development of multimodal imaging instrumentation, it is expected that this field will grow and more multipurpose agents, both for imaging and therapeutic applications will begin to appear in the literature.
Conclusion
This review documents many examples of CNT materials, which have been labeled with one or more imaging agents, and functionalized for water suspendability to image non-invasively.
While other CNT-based CAs have been synthesized for other imaging techniques, we have chosen to focus on those full-body imaging modalities most used in the clinic today (MRI, X-ray CT, SPECT, and PET), and therefore exhibit the most translational potential. The examples presented here have shown that appropriately functionalized CNT materials are a versatile platform with potential for a wide-range of imaging and therapeutic applications in medicine. In general, the studies reviewed have also shown that properly purified and derivatized CNT materials are non-toxic at reasonable clinical concentrations. While this is true for the nuclear imaging techniques of SPECT and PET, this is less certain for MR and X-ray CT imaging where concentrations in the millimolar range are required. In fact, new functionalization procedures aimed at increasing CNT agent suspendability into the millimolar range or above are still needed for toxicity and performance testing at these levels. For a complete discussion on the toxicity of CNTs, the authors direct the readers to the following review articles [121] [122] [123] .
Some of the currently accepted criteria for clinical imaging agents are that the agent should (1) be safe (non-toxic), (2) have sufficiently high performance for the imaging techniques needed and (3) be stable in vivo long enough to perform the imaging function until eventual elimination or biodegradation. In fact, recent research has focused on peroxidase-driven biodegradation of CNTs, and other natural enzymatic catalysis [124] [125] [126] . Finally and most importantly, the agent must be reproducible using good manufacturing practices as required by the U.S. Food and Drug Administration. This requirement implies that SWCNTs should be superior to MWCNTs for CNT-based agent design simply because MWCNTs are a far less uniform material.
While several CNT-based materials in the literature have already satisfied most of the above criteria, two major problems linger. Namely, more work is needed to create a more uniform particle distribution in both size (length) and degree of functionalization. Secondly, more preclinical data is needed which quantifies and potentially proves total elimination of the CNT agents from the body over time. Finally, CNT-based materials have been shown to surpass the performance of all other nanoparticle and small molecule CAs, while maintaining high biocompatibility. For example, the "Gadonanotubes" provide unrivaled performance as MRI CAs with relaxivities up to 40 times greater (on a per Gd 3+ -ion basis) than current Gd 3+ -based CAs in the clinic [63] . Studies have shown that this phenomenon is due to the encapsulation of Gd 3+ -ion clusters within the cavities of the US-SWCNTs and the special Gd 3+ ion-water interaction for that specific environment. Such findings provide us with valuable information about the physics behind the performance of the agents and about the contrast enhancement phenomenon, which allow us to possibly design more powerful CAs. This is just one of the many surprises that other new CNT-based CA might also provide. Therefore, the search for new CNT-based CAs should go on to explore the possibilities, while parallel efforts are also needed to seek pathways toward clinical approval for key CNT-based CAs that emerge from such studies.
